"We were delighted to find that patients who get the current state-of-the-art treatment with platelet blockers, medical treatment and stents during procedures had a significant improvement in their outcome, " said Dr. Christopher Cannon, an assistant professor at Harvard Medical School and a principal investigator for a number of heart-related studies at Brigham and Women's Hospital in Boston, Massachusetts.

CNN: Research closing in on heart disease